Abstract Details
|
Emma L. Wetmore, MD
PRESENTER |
Dr. Wetmore has nothing to disclose. |
| Diana Lehner-Gulotta, RD | Mrs. Lehner-Gulotta has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Functional Formularies. |
| Alyssa Beth Stotz, MS, NBC-HWC | Mrs. Stotz has nothing to disclose. |
| Claire Har, Jr., MPH | Ms. Har has nothing to disclose. |
| Ilana L. Kahn, MD (Childrens National Medical Center) | Dr. Kahn has nothing to disclose. |
| James N. Brenton, MD, FAAN | Dr. Brenton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for I-ACT on a Novartis sponsored project. The institution of Dr. Brenton has received research support from NIH/NINDS. The institution of Dr. Brenton has received research support from Autoimmune Encephalitis Alliance. Dr. Brenton has received publishing royalties from a publication relating to health care. Dr. Brenton has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with Department of Defense. Dr. Brenton has received personal compensation in the range of $0-$499 for serving as a Grant Reviewer with NIH. Dr. Brenton has received personal compensation in the range of $0-$499 for serving as a Grant Reviewer with FDA. |